Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Liver Int. 2013 Oct 1;34(6):e118–e127. doi: 10.1111/liv.12312

Table 2.

Patient Characteristics by disease group

Factor Steatosis (n=67) NASH(n=81)
Age 47.9 ± 12.3 51.4 ± 12.2
Gender (M:F) 18:49 24:57
Height(cm) 165.3 ± 9.0 165.5 ± 10.5
Weight(lbs) 214.3 ± 60.1 219.2 ± 48.0
Body mass index (kg/m2) 35.2 ± 7.8 36.1 ± 6.2
Glucose (mg/dl) 109.3 ± 35.5 123.8 ± 40.8*
Insulin (mU/L) 18.1 ± 11.1 27.5 ± 21.6**
HOMA IR 5.0 ± 3.9 9.3 ±10.4**
HbA1c gm% 6.2± 1.0 6.6 ± 1.6
Steatosis 1.2±0.8 2.3 ± 0.7***
Inflammation 0.9z ± 0.4 1.5 ± 0.7***
Fibrosis 1.0 ± 0.3 2.1 ± 1.2***
Ballooning 0.12 ± 0.03 1.4 ± 0.5***
NAS 2.3 ± 1.0 5.3 ± 1.1***
AST 33.6 ± 18.5 45.5 ± 26.9**
ALT 38.3 ± 29.9 52.2 ± 28.6**
Bilirubin 0.6 ± 0.3 0.8 ±0.4
Vitamin D (ng/ml) 25.0 ± 11.3 18.1 ± 8.4***
Fat wt (lb) 79.9 ± 33.0 78.7 ± 29.8
FFM wt(lb) 134.2 ± 37.4 140.5 ± 37.3
Fat mass/FFM 0.64 ± 0.24 0.59 ± 0.24
Fat % of wt 36.6 ± 8.7 35.7 ± 10.1
FFM % of wt 63.4 ± 8.7 64.3 ± 10.1

Values presented as Mean ± SD.

*

p<0.05

**

p<0.01;

***

p<0.001